Hoth Therapeutics reports clinical data for cancer skin toxicity drug

Go back to Hoth Therapeutics reports clinical data for cancer skin toxicity drug
(NASDAQ: HOTH) Delayed: 1.36 --0 (-0%)
Previous Close $1.36    52 Week High
Open $1.36    52 Week Low
Day High $1.36    P/E N/A 
Day Low $1.36    EPS
Volume 64,505